A New Era in HIV Prevention: Monthly Pills and Long-Acting Injections Transform PrEP

The global fight against Human Immunodeficiency Virus (HIV) has seen incredible progress, yet the need for innovative prevention methods remains urgent. In 2023 alone, 1.3 million people acquired HIV, underscoring the continuous demand for effective strategies. Among the most powerful tools in this fight is pre-exposure prophylaxis, or PrEP